Frequently Asked Questions (FAQs)

Please email us at present@bio.org.

Company Presentations at the CEO & Investor Conference are 13-minute presentations given by senior-level executives. They showcase a company’s pipeline, R&D activities, business objectives and investment goals. For the 2022 CEO & Investor Conference, the presentations can be given in person, virtually, or both.

Companies and organizations present at the CEO & Investor Conference to get in front of an exclusive audience of public and private equity investors, plus other biotech executives. Presenters also receive exclusive benefits not available to general attendees, including pre-conference marketing (such as email newsletters, press releases, etc.), designation in the One-on-One Partnering System, and the opportunity to also provide a Company Presentation video to share online.

The CEO & Investor  Conference will feature presentations across the stages of biotech.  This will include a smaller group of early stage with a larger group of established private companies and including publicly funded companies. Those interested in presenting must have a clear R&D focus, with a pipeline involving biotechnology therapeutics, diagnostics, or platform technologies. This can include patient advocacy groups. Service providers will not be considered, but should email our Sponsorship Team to discuss alternative ways to highlight your initiatives with a dedicated team member. For companies looking to participate in the Discovery or Emerging Innovators Tracks, there are additional financial qualifications, explained in more detail on the registration page. All applications submitted will be reviewed and appropriate companies will be approved to present.

All presentations are 13 minutes in length.

Submit an application! All companies and organizations that are interested in presenting are encouraged to submit an application here. Your application will be reviewed, and you will be notified shortly of its status. Should your application be accepted, registration and logistical details would then be provided.

The deadline to submit an application is January 28.  However, in-person presentation space is limited, and applications should be submitted as soon as possible. Once presentation spots are sold out, applications will be wait-listed, and companies will be notified if/when a presentation slot becomes available.

Yes. The presenter must purchase a registration pass in order to give them access to the sessions, BIO One-on-One Partnering, and networking events. There is also an additional presentation fee.   For more information on registration and presentation pricing, please visit our registration page.

All registered attendees and investors have full access to the company presentations at this event.

In-person presenters will need to upload their presentations onsite.  Virtual presenting companies will need to submit an mp4 file of their presentation about two weeks before the event.  Approved presenters will receive detailed instructions on what to submit and the next steps.  Or if you have more questions, please reach out to present@bio.org.

Designed for maximum flexibility, in-person attendance provides access to meet with other in-person attendees on-site in New York during conference hours Monday, February 14, and Tuesday, February 15. In addition, in-person attendees can take virtual meetings, hosted through unique, secure BIO-provided Zoom links, outside conference hours and on Wednesday, February 16, and Thursday, February 17.

Virtual attendance provides access to take virtual meetings hosted via BIO-provided Zoom links Monday, February 14 through Thursday, February 17.

The BIO One-On-One Partnering™ system works on a company-to-company basis. Delegates’ accounts will be placed into a company profile with their colleagues as they register. After filling out their profiles and their calendar availability, delegates send meeting requests to other companies and investors of interest and accept incoming meeting requests as appropriate.

Once a meeting request has been accepted, there is nothing more you need to do to get it scheduled. All meetings will be scheduled by BIO and provided an appropriate location, whether in-person or virtual, to accommodate the meeting participants’ attendance type and calendar availability.

You can expect to find senior biotech executives, and business development leaders from leading companies, and analysts and investors from premier firms participating in partnering in-person in New York or attending virtually from around the globe.

Please submit attendance type change requests by email to customercare@bio.org and biopartnering@bio.org before January 20, 2022.

In-person partnering meetings will be held Monday, February 14 and Tuesday, February 15 at the New York Marriott Marquis during conference hours and virtual partnering meetings will be held  Monday, February 14 through Thursday, February 17 via unique, secure BIO-provided Zoom links.

Each company profile is allowed 150 outstanding outgoing meeting requests. Once an outgoing meeting request is accepted, declined, or canceled, it no longer counts against that limit, and you can send an additional meeting request. 

Completed registration at a rate including partnering (Premier Access, Emerging/Discovery/Government/Academic/Non-Profit, qualified Investors) is required for access to BIO One-on-One Partnering™ for the 2022 BIO CEO & Investor Conference. The partnering system will open in early January 2022. After the system opens, you can expect to receive your partnering login information within 1 business day of your completed registration. Be sure to add noreply.partnering@bio.org to your safe sender's list to receive your partnering access instructions.

Check out our Quick Start Guide PDF for best partnering practices. For further assistance, please contact biopartnering@bio.org.